当前位置: 首页 > 详情页

Cells therapy for Parkinson's disease-so close and so far away

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]Cell Therapy Center, Xuanwu Hospital, Capital Medical University and Key Laboratory of Neurodegeneration, Ministry of Education, Beijing 100053, China
出处:
ISSN:

关键词: Parkinson's disease dopamine neurons cell replacement transplantation stem cell fetal ventral mesencephalon carotid body embryonic stem cells nuclear transfer embryonic stem cells induced pluripotent stem cells

摘要:
One of the strategies of treating Parkinson's disease (PD) is the replacement of lost neurons in the substantia nigra with healthy dapamingergic cells. Potential sources for cells range from autologous grafts of dopamine secreting cells, fetal ventral mesencephalon tissue, to various stem cell types. Over the past quarter century, many experimental replacement therapies have been tried on PD animal models as well as human patients, yet none resulted in satisfactory outcomes that warrant wide applications. Recent progress in stem cell biology has shown that nuclear transfer embryonic stem cells (ntES) or induced pluripotent stem cells (iPS) derived cells can be used to successfully treat rodent PD models, thus solving the problem of immunorejection and paving the way for future autologous transplantations for treating PD. Meanwhile, however, post mortem analysis of patients who received fetal brain cell transplantation revealed that implanted cells are prone to degeneration just like endogenous neurons in the same pathological area, indicating long-term efficacy of cell therapy of PD needs to overcome the degenerating environment in the brain. A better understanding of neurodegeneration in the midbrain appeared to be a necessary step in developing new cell therapies in Parkinson's disease. It is likely that future cell replacement will focus on not only ameliorating symptoms of the disease but also trying to slow the progression of the disease by either neuroprotection or restoring the micro-environment in the midbrain.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2008]版:
大类 | 4 区 生物
小类 | 4 区 生物学
最新[2023]版:
JCR分区:
出版当年[2007]版:
Q3 BIOLOGY
最新[2023]版:

影响因子: 最新[2023版] 最新五年平均 出版当年[2007版] 出版当年五年平均 出版前一年[2006版] 出版后一年[2008版]

第一作者:
第一作者机构: [1]Cell Therapy Center, Xuanwu Hospital, Capital Medical University and Key Laboratory of Neurodegeneration, Ministry of Education, Beijing 100053, China
通讯作者:
通讯机构: [1]Cell Therapy Center, Xuanwu Hospital, Capital Medical University and Key Laboratory of Neurodegeneration, Ministry of Education, Beijing 100053, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院